Incorrectly matching a patient to a health record may have patient safety, privacy, and security implications.
Accurate and efficient matching of individual patients to their health records across settings is a wonderful thing if w...
Both this recoupment of investment and these profits are jeopardized by lawsuits that are filed by generics.
I think that encapsulates pretty well their approach, and I wish we had a little more time to discuss that but perhaps a...
Whereas, with Rule of Reason analysis they could continue to take into account the presumption of patent validity and th...
By the way, when we're in the context of a patent, isn't there something sort of internally inconsistent or contradictor...
In your testimony you note that we have a statutory directive that exists under current law that all patents are to be p...
We don't want anti-competitive behavior in our marketplace.
But to the extent that the existence of the patent and the existence of the current patent term as we have it set up, fa...
And it's for that very reason that the Supreme Court has tended, over the course of the last century, to lean more towar...
Mr. Orszag, so much of the discussion today, including some of your discussion with Senator Klobuchar, has focused on th...
A presumption of illegality is proper only when 'an observer with even a rudimentary understanding of economics could co...
I think you have to presume that the patent is invalid in order, legitimately, to call it pay for delay.
Running against the shot clock here--it's something we deal with a lot in the Senate.
Our laws create a statutory presumption as to the patent's validity.
Some brand-name manufacturers have chosen to settle lawsuits filed by generics instead of litigating.
Wouldn't you have to concede that then in that circumstance you've got pro-competitive effects?
I want to talk just a little bit about our use of the term 'pay for delay' today.
